Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
16.37
+0.46 (2.89%)
At close: Oct 22, 2026, 4:00 PM EDT
15.97
-0.40 (-2.44%)
Pre-market: Oct 23, 2026, 4:15 AM EDT
Perrigo Company Market Cap
Perrigo Company has a market cap or net worth of $2.27 billion as of October 22, 2026. It is the 6,058th most valuable company in the world and the 1,681st biggest in the United States. Its market cap has decreased by 24.71% in one year.
Market Cap
2.27B
Enterprise Value
5.35B
1-Year Change
-24.71%
Global Rank
Country Rank
#1,681 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Perrigo Company's market cap has increased from $622.50M to $2.27B, an increase of 264.92%. That is a compound annual growth rate of 4.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 2.27B | 18.58% |
| Dec 31, 2025 | 1.92B | -45.38% |
| Dec 31, 2024 | 3.51B | -19.56% |
| Dec 29, 2023 | 4.36B | -5.00% |
| Dec 30, 2022 | 4.59B | -11.80% |
| Dec 31, 2021 | 5.20B | -14.75% |
| Dec 31, 2020 | 6.10B | -13.19% |
| Dec 31, 2019 | 7.03B | 33.57% |
| Dec 31, 2018 | 5.26B | -57.12% |
| Dec 29, 2017 | 12.28B | 2.87% |
| Dec 30, 2016 | 11.93B | -43.67% |
| Dec 31, 2015 | 21.18B | -5.39% |
| Dec 31, 2014 | 22.39B | 54.74% |
| Dec 31, 2013 | 14.47B | 48.17% |
| Dec 31, 2012 | 9.77B | 7.71% |
| Dec 30, 2011 | 9.07B | 55.24% |
| Dec 31, 2010 | 5.84B | 60.58% |
| Dec 31, 2009 | 3.64B | 22.02% |
| Dec 31, 2008 | 2.98B | -8.90% |
| Dec 31, 2007 | 3.27B | 104.21% |
| Dec 29, 2006 | 1.60B | 15.06% |
| Dec 30, 2005 | 1.39B | 13.24% |
| Dec 31, 2004 | 1.23B | 11.97% |
| Dec 31, 2003 | 1.10B | 30.33% |
| Dec 31, 2002 | 842.80M | -3.10% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 2.52B |
| Bausch Health Companies | 2.41B |
| Supernus Pharmaceuticals | 2.40B |
| Prestige Consumer Healthcare | 2.27B |
| Trulieve Cannabis | 2.12B |
| BioCryst Pharmaceuticals | 1.98B |
| Xeris Biopharma Holdings | 1.97B |
| Alvotech | 1.83B |